Full Text View
Tabular View
No Study Results Posted
Related Studies
Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat
This study has been completed.
Study NCT00525044   Information provided by Boehringer Ingelheim Pharmaceuticals

First Received on September 3, 2007.   Last Updated on May 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pharyngitis
More general conditions related to this trial
Otorhinolaryngologic Diseases
Pharyngeal Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Stomatognathic Diseases
Interventions listed in this trial
Ambroxol
Placebo
More general drug interventions related to this trial
Expectorants
Pharmacologic Actions
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services